08/31/2026
Meaningful progress in access to CAR-T will require not only continued scientific innovation, but also coordinated policy reform, regulatory collaboration, and sustained investment in modernizing the systems that ultimately determine who benefit from these transformative therapies.
Read more in The Hematologist: https://ow.ly/aEaR50ZGHh8